Herein we present the expedient synthesis of endomorphin-1 analogues containing stereoisomeric β2-homo-Freidinger lactam-like scaffolds ([Amo2]EM), and we discuss opioid receptor (OR) affinity, enzymatic stability, functional activity, in vivo antinociceptive effects, and conformational and molecular docking analysis. Hence, H-Tyr-Amo-Trp-PheNH2 resulted to be a new chemotype of highly stable, selective, partial KOR agonist inducing analgesia, therefore displaying great potential interest as a painkiller possibly with reduced harmful side effects.

Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist / De Marco, Rossella; Bedini, Andrea; Spampinato, Santi*; Comellini, Lorenzo; Zhao, Junwei; Artali, Roberto; Gentilucci, Luca. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 61:13(2018), pp. 5751-5757. [10.1021/acs.jmedchem.8b00296]

Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist

De Marco, Rossella;Bedini, Andrea;Spampinato, Santi
;
Zhao, Junwei;Artali, Roberto;Gentilucci, Luca
2018

Abstract

Herein we present the expedient synthesis of endomorphin-1 analogues containing stereoisomeric β2-homo-Freidinger lactam-like scaffolds ([Amo2]EM), and we discuss opioid receptor (OR) affinity, enzymatic stability, functional activity, in vivo antinociceptive effects, and conformational and molecular docking analysis. Hence, H-Tyr-Amo-Trp-PheNH2 resulted to be a new chemotype of highly stable, selective, partial KOR agonist inducing analgesia, therefore displaying great potential interest as a painkiller possibly with reduced harmful side effects.
2018
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist / De Marco, Rossella; Bedini, Andrea; Spampinato, Santi*; Comellini, Lorenzo; Zhao, Junwei; Artali, Roberto; Gentilucci, Luca. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 61:13(2018), pp. 5751-5757. [10.1021/acs.jmedchem.8b00296]
De Marco, Rossella; Bedini, Andrea; Spampinato, Santi*; Comellini, Lorenzo; Zhao, Junwei; Artali, Roberto; Gentilucci, Luca
File in questo prodotto:
File Dimensione Formato  
Constraining Endomorphin‑1.pdf

Open Access dal 15/06/2019

Tipo: Postprint
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 925.59 kB
Formato Adobe PDF
925.59 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/666375
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact